Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
zoledronic acid (zometa) (1 trial)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 2)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 2)
Trials (1 total)
Trial APIs (1 total)